Hepatitis C Virus-Related Acute and Chronic Hepatitis in Hemodialysis Patients

Pluvio, M; Saggese, Antonio; Cirillo, D; Castellino, Pietro; Pempinello, R.; Iannece, M.D.; Guarnaccia, D.; Tassinaro, P.; Pluvio, C.; Cicchella, T.; Pasquale, Carmine G. De

doi:10.1159/000186923

Cited by 4 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Blood transfusions could be responsible for the high prevalence of anti-HCV found in the current study. Blood transfusions can be a source for anti-HCV positivity according to reports [78] [79] though reports to the contrary also exist [80] . However, data on correlation between anti-HCV positivity and history of blood transfusion in dialysis patients is conicting.…”

Section: Resultsmentioning

confidence: 99%

Hepatitis C Virus Antibodies Among Hemodialysis Patients in Makkah City, Kingdom of Saudi Arabia

Al-Khattabi¹

2019

ijsr

View full text Add to dashboard Cite

BACKGROUND: Hepatitis C virus (HCV) infection is the most common cause of chronic liver disease in the world and evaluation of the epidemiology of HCV infection was made possible by the development of a serological assay to detect antibodies to epitopes of HCV. Hemodialysis (HD) is considered to be one of the main risk factors of HCV transmission. The prevalence of antibodies to HCV (anti-HCV) in patients undergoing maintenance dialysis therapy (MDT) was found to be one of the highest among different risk groups and there is wide variation in the prevalence of HCV infection among different dialysis units and countries. Therefore, the prevalence of anti-HCV was studied in patients undergoing MDT. MATERIALS AND METHODS:The current study is a cross section one, where a sample of 361 HD patients were selected randomly from HD centers in three governmental hospitals in Makkah city and they were subjected to assessment for the prevalence of anti-HCV by using questionnaires in addition to clinical measurements. RESULTS:. The overall prevalence of anti-HCV among HD patients was 49.9% according to clinical measurements and questionnaire CONCLUSION: The overall prevalence of anti-HCV among HD patients in Makkah city (49.9%) was comparable to that reported from other parts of the Kingdom of Saudi Arabia (KSA) and it is almost similar to the already reported positivity rate of (43.2%) from t eastern region of KSA [1] and southern regions of KSA (45.5%). [2, 3] However, Strict adherence to universal precautions as recommended by the Center for Diseases Control (CDC), meticulous regular disinfection of HD machines, Strict isolation of HCV-positive patients, dedicated dialysis machines and nursing staff at new dialysis set-up could possibly be the reasons of relatively low anti-HCV positivity at the current study than that reported by Shaheen, et al [3,4] , from four centers in the western region of KSA, (72.3%) and that by Huraib, et al [5] [6] in their multi-center study in KSA, (68%) as well as the mean national rate. [3,7] On the other hand, the use of more sensitive third generation enzyme -linked immunosorbent assay (ELISA) technique, long duration on HD, multiple blood transfusions, patients with dialysis treatment in multi-centers, factors related to infrastructure, environment and operational system might be responsible for the high prevalence of anti-HCV found in this study than that reported earlier by Saeed, et al [8] from Riyadh and those observed in the central region of KSA.[9]Although routes of transmission are still unclear, early detection of all infected patients is mandatory for HCV prophylaxis in HD patients. Furthermore, an intensive educational program for staff members, HD patients and proper evaluation of the HD situation are needed. Thus, observation of appropriate preventive measures by all HDcenters is paramount.

show abstract

Section: Resultsmentioning

confidence: 99%

Hepatitis C Virus Antibodies Among Hemodialysis Patients in Makkah City, Kingdom of Saudi Arabia

Al-Khattabi¹

2019

ijsr

View full text Add to dashboard Cite

show abstract

“…Blood transfusions could be responsible for the high prevalence of anti-HCV found in the current study. Blood transfusions can be a source for anti-HCV positivity according to reports [78,79] though reports to the contrary also exist [80]. However, data on correlation between anti-HCV positivity and history of blood transfusion in dialysis patients is conflicting.…”

Section: Discussionmentioning

confidence: 99%

Hepatitis C Infection in Hemodialysis Patients, Makkah, Saudi Arabia

Ghanim Hamid Al-Khattabi

2024

ARASET

View full text Add to dashboard Cite

Hepatitis C virus (HCV) infection is the most common cause of chronic liver disease in the world and evaluation of the epidemiology of HCV infection was made possible by the development of a serological assay to detect antibodies to epitopes of HCV. Hemodialysis (HD) is considered to be one of the main risk factors of HCV transmission. The prevalence of antibodies to HCV (anti-HCV) in patients undergoing maintenance dialysis therapy (MDT) was found to be one of the highest among different risk groups and there is wide variation in the prevalence of HCV infection among different dialysis units and countries. Therefore, the prevalence of anti-HCV was studied in patients undergoing MDT. The current study is a cross section one, where a sample of 361 HD patients were selected randomly from HD centres in three governmental hospitals in Makkah city and they were subjected to assessment for the prevalence of anti-HCV by using questionnaires in addition to clinical measurements. The overall prevalence of anti-HCV among HD patients was 49.9% according to clinical measurements and questionnaires. The overall prevalence of anti-HCV among HD patients in Makkah city (49.9%) was comparable to that reported from other parts of the Kingdom of Saudi Arabia (KSA) and it is almost similar to the already reported positivity rate of (43.2%) from the eastern region of KSA and southern regions of KSA (45.5%). However, Strict adherence to universal precautions as recommended by the Centre for Diseases Control (CDC), meticulous regular disinfection of HD machines, Strict isolation of HCV-positive patients, dedicated dialysis machines and nursing staff at new dialysis set-up could possibly be the reasons of relatively low anti-HCV positivity at the current study than that reported by Shaheen et al., from four centres in the western region of KSA, (72.3%) and that by Huraib et al., in their multi-centre study in KSA, (68%) as well as the mean national rate. On the other hand, the use of more sensitive third generation enzyme - linked immunosorbent assay (ELISA) technique, long duration on HD, multiple blood transfusions, patients with dialysis treatment in multi-centres, factors related to infrastructure, environment and operational system might be responsible for the high prevalence of anti-HCV found in this study than that reported by Saeed et al., from Riyadh and those observed in the central region of KSA. Although routes of transmission are still unclear, early detection of all infected patients is mandatory for HCV prophylaxis in HD patients. Furthermore, an intensive educational program for staff members, HD patients and proper evaluation of the HD situation are needed. Thus, observation of appropriate preventive measures by all HD-centres is paramount.

show abstract

“…Blood transfusions could be responsible for the high prevalence of anti-HCV found in the current study. Blood transfusions can be a source for anti-HCV positivity according to reports [78][79] though reports to the contrary also exist [80] . However, data on correlation between anti-HCV positivity and history of blood transfusion in dialysis patients is conflicting.…”

Section: Discussionmentioning

confidence: 99%

Antibodies Against Hepatitis C Virus (Anti-HCV) among Hemodialysis Patients in Makkah, Saudi Arabia

Al-Khattabi

2022

ARASET

View full text Add to dashboard Cite

Hepatitis C virus (HCV) infection is the most common cause of chronic liver disease in the world and evaluation of the epidemiology of HCV infection was made possible by the development of a serological assay to detect antibodies to epitopes of HCV. Hemodialysis (HD) is considered to be one of the main risk factors of HCV transmission. The prevalence of antibodies to HCV (anti-HCV) in patients undergoing maintenance dialysis therapy (MDT) was found to be one of the highest among different risk groups and there is wide variation in the prevalence of HCV infection among different dialysis units and countries. Therefore, the prevalence of anti-HCV was studied in patients undergoing MDT. The current study is a cross section one, where a sample of 361 HD patients were selected randomly from HD centers in three governmental hospitals in Makkah city and they were subjected to assessment for the prevalence of anti-HCV by using questionnaires in addition to clinical measurements. The overall prevalence of anti-HCV among HD patients was 49.9% according to clinical measurements and questionnaires. The overall prevalence of anti-HCV among HD patients in Makkah city (49.9%) was comparable to that reported from other parts of the Kingdom of Saudi Arabia (KSA) and it is almost similar to the already reported positivity rate of (43.2%) from the eastern region of KSA and southern regions of KSA (45.5%). However, strict adherence to universal precautions as recommended by the Center for Diseases Control (CDC), meticulous regular disinfection of HD machines, strict isolation of HCV-positive patients, dedicated dialysis machines and nursing staff at new dialysis set-up could possibly be the reasons of relatively low anti-HCV positivity at the current study than that reported by Shaheen et al [34], from four centers in the western region of KSA, (72.3%) and that by Huraib et al [29] in their multi-center study in KSA, (68%) as well as the mean national rate. On the other hand, the use of more sensitive third generation enzyme - linked immunosorbent assay (ELISA) technique, long duration on HD, multiple blood transfusions, patients with dialysis treatment in multi-centers, factors related to infrastructure, environment and operational system might be responsible for the high prevalence of anti-HCV found in this study than that reported by Saeed, et al from Riyadh and those observed in the central region of KSA. Although routes of transmission are still unclear, early detection of all infected patients is mandatory for HCV prophylaxis in HD patients. Furthermore, an intensive educational program for staff members, HD patients and proper evaluation of the HD situation are needed. Thus, observation of appropriate preventive measures by all HD-centers is paramount.

show abstract

Hepatitis C Virus-Related Acute and Chronic Hepatitis in Hemodialysis Patients

Cited by 4 publications

References 1 publication

Hepatitis C Virus Antibodies Among Hemodialysis Patients in Makkah City, Kingdom of Saudi Arabia

Hepatitis C Virus Antibodies Among Hemodialysis Patients in Makkah City, Kingdom of Saudi Arabia

Hepatitis C Infection in Hemodialysis Patients, Makkah, Saudi Arabia

Antibodies Against Hepatitis C Virus (Anti-HCV) among Hemodialysis Patients in Makkah, Saudi Arabia

Contact Info

Product

Resources

About